Nectar Lifescience Ltd Annually Results

Gross Sales

1,925.83

1,746.56

1,925.52

1,763.74

2,642.86

Excise Duty

241.75

222.89

256.69

220.44

276.48

Net Sales

1,684.09

1,523.67

1,668.83

1,543.3

2,366.38

Other Operating Income

1.55

0.94

0.03

1.07

0.36

Other Income

13.03

42.24

11.29

2.72

4.01

Total Income

1,698.66

1,566.85

1,680.15

1,547.09

2,370.74

Total Expenditure

1,532.53

1,470.66

1,510.29

1,459.57

2,146.68

PBIDT

166.13

96.19

169.86

87.52

224.06

Interest

87.14

79.49

78.81

112.03

125.83

PBDT

78.99

16.7

91.05

-24.51

98.24

Depreciation

60.72

59.12

56.97

60.25

60.77

Minority Interest Before NP

0

0

0

0

0

Tax

0

0

0

8.59

1.66

Deferred Tax

13.27

-18.24

9.03

-20.09

4.02

Reported Profit After Tax

4.99

-24.18

25.05

-73.26

31.79

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

4.99

-24.18

25.05

-73.26

31.79

Extra-ordinary Items

0

0

0

-22.75

0

Adjusted Profit After Extra-ordinary item

4.99

-24.18

25.05

-50.51

31.79

EPS (Unit Curr.)

0.22

-1.08

1.15

-3.27

1.42

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

5

Equity

22.43

22.43

22.43

22.43

22.43

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

9.86

6.31

10.17

5.67

9.46

PBDTM(%)

4.69

1.09

5.45

-1.58

4.15

PATM(%)

0.29

-1.58

1.5

-4.74

1.34